Your session is about to expire
← Back to Search
Antihypertensive Treatment for Postpartum Hypertension (P-PAT Trial)
P-PAT Trial Summary
This trial will compare whether treating hypertension in the postpartum period decreases postpartum hypertension and its associated maternal morbidity.
P-PAT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowP-PAT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.P-PAT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You gave birth within the last 96 hours.I was diagnosed with preeclampsia during or right after my pregnancy.More than 30% of your blood pressure readings after giving birth were high (systolic 140 or higher OR diastolic 90 or higher).I started blood pressure medication after giving birth due to high readings.I was diagnosed with preeclampsia after leaving the hospital from giving birth.I am 18 years old or older.I have long-term high blood pressure and now also have preeclampsia.More than half of the blood pressure readings after giving birth were within the normal range (systolic less than 140 AND diastolic less than 90).
- Group 1: Treatment
- Group 2: No-treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can people with the qualifying condition still enroll in this trial?
"That is accurate. The clinical trial in question, as indicated by its listing on clinicaltrials.gov, is looking for volunteers. This particular study was first posted on 7/17/2020 and was updated on 11/24/2021; it hopes to enroll 300 people at 1 location."
What conditions are Labetalol and Nifedipine generally prescribed for?
"Labetalol and nifedipine are most often given to patients with vasospastic angina, but the medication can also have other benefits for those with conditions like pheochromocytomas, high altitude sickness, and premature labor."
What are the side effects of Labetalol, Nifedipine?
"Labetalol and nifedipine have been studied before and shown to be safe, so they received a score of 3."
What other medical studies have included Labetalol and Nifedipine?
"As of right now, there are 19 ongoing clinical trials for Labetalol, Nifedipine. 3 of those active clinical trials are currently in Phase 3. Although the majority of trials for Labetalol, Nifedipine originate from Breckenridge, Colorado - with 94 locations running trials in total - across the United States of America."
How many people have signed up to participate in this experiment?
"That is correct, as of now this study is still looking for patients. The earliest date that this information was posted was on July 17th, 2020 with the most recent update being on November 24th, 2021. They are searching for a total of 300 individuals across 1 location."
Is this a new type of clinical trial?
"Labetalol, Nifedipine has been under research for over a decade. In 2007, Encysive Pharmaceuticals ran the first study and 27 participants. After review by an authoritative body, Labetalol, Nifedipine was approved for Phase 2 drug trials. Now, there are 19 live trials in 66 cities and 6 countries."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger